Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2009 | 1 |
2010 | 3 |
2011 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.
Blood. 2010 Apr 15;115(15):3109-17. doi: 10.1182/blood-2009-04-214957. Epub 2010 Feb 3.
Blood. 2010.
PMID: 20130243
Free PMC article.
Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream.
Smith P, Yao W, Shepard S, Covington M, Lee J, Lofland J, Naim A, Sheth T, Parikh B, Yeleswaram S.
Smith P, et al. Among authors: shepard s.
Pharmaceutics. 2021 Jul 8;13(7):1044. doi: 10.3390/pharmaceutics13071044.
Pharmaceutics. 2021.
PMID: 34371735
Free PMC article.
Review.
Item in Clipboard
Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction.
Lin Q, Meloni D, Pan Y, Xia M, Rodgers J, Shepard S, Li M, Galya L, Metcalf B, Yue TY, Liu P, Zhou J.
Lin Q, et al. Among authors: shepard s.
Org Lett. 2009 May 7;11(9):1999-2002. doi: 10.1021/ol900350k.
Org Lett. 2009.
PMID: 19385672
Item in Clipboard
Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.
Fridman JS, Scherle PA, Collins R, Burn T, Neilan CL, Hertel D, Contel N, Haley P, Thomas B, Shi J, Collier P, Rodgers JD, Shepard S, Metcalf B, Hollis G, Newton RC, Yeleswaram S, Friedman SM, Vaddi K.
Fridman JS, et al. Among authors: shepard s.
J Invest Dermatol. 2011 Sep;131(9):1838-44. doi: 10.1038/jid.2011.140. Epub 2011 Jun 16.
J Invest Dermatol. 2011.
PMID: 21677670
Free article.
Item in Clipboard
Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1/2 inhibitor, in humans.
Shilling AD, Nedza FM, Emm T, Diamond S, McKeever E, Punwani N, Williams W, Arvanitis A, Galya LG, Li M, Shepard S, Rodgers J, Yue TY, Yeleswaram S.
Shilling AD, et al. Among authors: shepard s.
Drug Metab Dispos. 2010 Nov;38(11):2023-31. doi: 10.1124/dmd.110.033787. Epub 2010 Aug 10.
Drug Metab Dispos. 2010.
PMID: 20699411
Clinical Trial.
Item in Clipboard
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050.
Fridman JS, Scherle PA, Collins R, Burn TC, Li Y, Li J, Covington MB, Thomas B, Collier P, Favata MF, Wen X, Shi J, McGee R, Haley PJ, Shepard S, Rodgers JD, Yeleswaram S, Hollis G, Newton RC, Metcalf B, Friedman SM, Vaddi K.
Fridman JS, et al. Among authors: shepard s.
J Immunol. 2010 May 1;184(9):5298-307. doi: 10.4049/jimmunol.0902819. Epub 2010 Apr 2.
J Immunol. 2010.
PMID: 20363976
Item in Clipboard
Metathesis approach to the synthesis of polyheterocyclic structures from oxanorbornenes.
Winkler JD, Asselin SM, Shepard S, Yuan J.
Winkler JD, et al. Among authors: shepard s.
Org Lett. 2004 Oct 14;6(21):3821-4. doi: 10.1021/ol0484106.
Org Lett. 2004.
PMID: 15469358
Item in Clipboard
Cite
Cite